Genepoint Biological Technology

Genepoint Biological Technology

Genepoint Biological Technology is a healthcare Company.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
*

$29.5m

Series D
Total Funding000k
Notes (0)
More about Genepoint Biological Technology
Made with AI
Edit

Genepoint Biological Technology, established in Shanghai in July 2015, operates as a specialized provider of automated, intelligent solutions for the low-temperature preservation of biological resources. The company was founded by Chen Zhehua, who holds an MBA from Tongji University and previously served as the China Business Development Manager at Air Products (China) Investment Co., Ltd., where he was instrumental in developing the company's medical business sector. Genepoint has secured significant venture capital, with its latest Series D funding round in January 2023 raising nearly $29.5 million, led by investors such as Shanghai Guofang Private Equity Fund Management, LYFE Capital, and Huajin Capital.

The firm's business model is centered on the in-house research, development, and manufacturing of advanced cryogenic robotic systems and automated ultra-low temperature storage solutions. Its client base includes top-tier gene banks, research universities, hospitals, and biopharmaceutical facilities, primarily across Asia. Genepoint generates revenue through the sale of its specialized equipment and consumables. The company has established a strong market presence, underscored by its portfolio of over 220 patents and a research and development team that constitutes more than 32% of its workforce.

Genepoint's product suite offers comprehensive solutions for the entire bio-sample storage management process. Key offerings include the 'Hatch' series, a fully automated cryogenic robot and repository system for fast, intelligent retrieval of samples in liquid nitrogen environments. Its 'Hatch-Lite' model was recognized with the ISBER Outstanding New Product Award in 2019, a first for an Asian company in this category. Another core product, the 'Snorkel' Automated Sample Repository System, integrates advanced refrigeration technology and user-friendly intelligent interaction for efficient sample management. The 'Crest' line consists of intelligent cryogenic storage systems that maintain temperatures below -180°C using advanced vacuum extraction and insulation technology. To complement its automated systems, the company provides a range of consumables under the 'Sinfo' brand, including co-molded cryotubes designed for both automated and manual applications.

Keywords: cryogenic automation, biological sample storage, automated biobanking, ultra-low temperature freezers, liquid nitrogen storage, laboratory automation, sample management systems, life sciences equipment, biopharmaceutical storage, robotic sample handling, cryopreservation solutions, intelligent storage systems, cryotubes, automated sample repository, cell storage automation, gene bank technology, cryogenic robotics, sample traceability, labware, biorepository solutions

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo